New onset psoriasis after rituximab for treatment of idiopathic membranous nephropathy

Nephrology

Volumn 19, Issue 1, 2014, Pages 60-

  Mok, Maggie Ming Yee ^a   Yeung, Chi Keung ^a   Chan, Daniel Tak Mao ^a   Lo, Wai Kei ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b TUNG WAH HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB;

ADULT; CASE REPORT; CYTOKINE PRODUCTION; FAMILY HISTORY; HUMAN; IDIOPATHIC MEMBRANOUS NEPHROPATHY; LETTER; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; PUSTULAR PSORIASIS; RELAPSE; REMISSION; TREATMENT DURATION;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; MALE; MIDDLE AGED; PSORIASIS;

EID: 84890443063     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12147     Document Type: Letter

References (3)

1. Andrew SB, Vimal KD, Julie GM, et al. Rituximab therapy for membranous nephropathy: A systemic review. Clin. J. Am. Soc. Nephrol. 2009; 4: 734-744.
2. Guidelli GM, Fioravanti A, Rubegni P, et al. Induced psoriasis after rituximab therapy for rheumatoid arthritis: A case report and review of the literature. Rheumatol. Int. 2012; [Epub ahead of print].
3. De Silva BD, Benton EC, Tidman MJ,. Generalized pustular psoriasis following withdrawal of oral cyclosporin treatment for palmo-plantar pustulosis. Clin. Exp. Dermatol. 1999; 24: 10-13.